HK1162616A1 - Methods for determining the risk of prenatal complications - Google Patents

Methods for determining the risk of prenatal complications

Info

Publication number
HK1162616A1
HK1162616A1 HK12103231.9A HK12103231A HK1162616A1 HK 1162616 A1 HK1162616 A1 HK 1162616A1 HK 12103231 A HK12103231 A HK 12103231A HK 1162616 A1 HK1162616 A1 HK 1162616A1
Authority
HK
Hong Kong
Prior art keywords
risk
determining
methods
prenatal
complications
Prior art date
Application number
HK12103231.9A
Other languages
English (en)
Chinese (zh)
Inventor
Howard Cuckle
Kypros Nicolaides
Tarja Ahola
Leona Poon
Original Assignee
華萊克合股公司
胎兒醫學基金會
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40901463&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1162616(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 華萊克合股公司, 胎兒醫學基金會 filed Critical 華萊克合股公司
Publication of HK1162616A1 publication Critical patent/HK1162616A1/xx

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/021Measuring pressure in heart or blood vessels
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/471Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475Assays involving growth factors
    • G01N2333/515Angiogenesic factors; Angiogenin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/36Gynecology or obstetrics
    • G01N2800/368Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/50Determining the risk of developing a disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Cardiology (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Databases & Information Systems (AREA)
  • Data Mining & Analysis (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physiology (AREA)
  • Vascular Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK12103231.9A 2008-01-25 2012-04-02 Methods for determining the risk of prenatal complications HK1162616A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US2377608P 2008-01-25 2008-01-25
US2589008P 2008-02-04 2008-02-04
US6004808P 2008-06-09 2008-06-09
US6073208P 2008-06-11 2008-06-11
PCT/US2009/032062 WO2009094665A1 (fr) 2008-01-25 2009-01-26 Procédés de détermination du risque de complications prénatales

Publications (1)

Publication Number Publication Date
HK1162616A1 true HK1162616A1 (en) 2012-08-31

Family

ID=40901463

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12103231.9A HK1162616A1 (en) 2008-01-25 2012-04-02 Methods for determining the risk of prenatal complications

Country Status (9)

Country Link
US (5) US8647832B2 (fr)
EP (3) EP3109322A1 (fr)
CN (2) CN102216468B (fr)
AU (1) AU2009206243B2 (fr)
CA (2) CA2713229C (fr)
ES (2) ES2587077T3 (fr)
HK (1) HK1162616A1 (fr)
PL (1) PL2245180T3 (fr)
WO (1) WO2009094665A1 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002210403A1 (en) * 2000-10-20 2002-04-29 Como Biotech Aps Pregnancy-associated plasma protein-a2 (papp-a2)
CN102216468B (zh) * 2008-01-25 2014-06-11 珀金埃尔默健康科学股份有限公司 确定产前并发症风险的方法
US8876714B2 (en) * 2010-02-22 2014-11-04 Wallac Oy Systems and methods for assessing risk of chromosomal disorders
US20120142559A1 (en) * 2010-12-06 2012-06-07 Pronota N.V. Biomarkers and parameters for hypertensive disorders of pregnancy
US20140349881A1 (en) * 2011-12-15 2014-11-27 Pronota N.V. Biomarkers and parameters for preeclampsia
CN104380104B (zh) * 2012-04-24 2021-03-30 西门子医疗保健诊断公司 先兆子痫筛查法
EP2890816B1 (fr) * 2012-08-30 2019-06-05 Ansh Labs LLC Papp-a2 en tant que marqueur pour la surveillance, la prédiction et le diagnostic de la prééclampsie
US20140273025A1 (en) * 2013-03-15 2014-09-18 Wallac Oy System and method for determining risk of pre-eclampsia based on biochemical marker analysis
CN103207274B (zh) * 2013-04-28 2015-02-25 成都中医药大学 一种胎儿7号染色体异常疾病的筛查试剂盒
CN103278633B (zh) * 2013-04-28 2014-11-19 成都中医药大学 一种孕妇流产史筛查试剂盒
CN103235133B (zh) * 2013-04-28 2014-11-19 成都中医药大学 一种胎儿9号染色体异常疾病的筛查试剂盒
CN103235142B (zh) * 2013-04-28 2015-04-15 成都中医药大学 一种孕妇初次妊娠筛查试剂盒
US10183039B2 (en) 2013-07-15 2019-01-22 Vanderbilt University Methods for the production of collagen IV
WO2015148989A1 (fr) * 2014-03-27 2015-10-01 Wayne State University Systèmes et méthodes pour identifier et traiter des sujets présentant un risque de complications obstétriques
CN106662590A (zh) * 2014-05-16 2017-05-10 塞尚公司 早期胎盘胰岛素样肽(pro‑EPIL)
US10656163B2 (en) 2014-09-02 2020-05-19 Wallac Oy Method for determining risk of pre-eclampsia
WO2016042202A1 (fr) 2014-09-17 2016-03-24 Wallac Oy Procédé pour déterminer le risque de naissance avant terme
WO2016095789A1 (fr) * 2014-12-15 2016-06-23 The Chinese University Of Hong Kong Détection de taxons bactériens pour la prédiction d'une naissance avant terme après une intervention clinique
WO2016191793A1 (fr) 2015-06-02 2016-12-08 Medvet Science Pty Ltd Procédés de dépistage de la trisomie fœtale
KR101817180B1 (ko) * 2016-01-20 2018-01-10 이원다이애그노믹스(주) 염색체 이상 판단 방법
MX2020002788A (es) 2017-09-13 2020-09-14 Progenity Inc Biomarcadores de preeclampsia y sistemas y metodos relacionados.
EP4070113A4 (fr) 2019-12-04 2023-12-20 Biora Therapeutics, Inc. Évaluation de la prééclampsie à l'aide de dosages du facteur de croissance placentaire libre et dissocié
CN111370121A (zh) * 2020-02-21 2020-07-03 杭州市妇产科医院 早孕期非整倍体产前筛查标志物预测妊娠期高血压疾病的风险模型建立方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9812432D0 (en) * 1998-06-09 1998-08-05 Queen Mary & Westfield College Predictive test
GB0026823D0 (en) * 2000-11-02 2000-12-20 King S College London Diagnosis of pre-eclampsia
US7407659B2 (en) * 2002-07-19 2008-08-05 Beth Israel Deaconess Medical Center Methods of diagnosing pre-eclampsia or eclampsia
US20050255114A1 (en) * 2003-04-07 2005-11-17 Nuvelo, Inc. Methods and diagnosis for the treatment of preeclampsia
GB0317476D0 (en) * 2003-07-25 2003-08-27 Wright David E Methods and apparatus for screening for chromosomal abnormalities
WO2006034427A2 (fr) * 2004-09-20 2006-03-30 Proteogenix, Inc. Diagnostic d'aneuploidie foetale
US7727733B2 (en) * 2004-12-21 2010-06-01 Yale University Diagnosis of preeclampsia
GB0600916D0 (en) * 2006-01-17 2006-02-22 Perkinelmer Instr Las Inc detecting and predicting pre-eclampsia
CN102216468B (zh) * 2008-01-25 2014-06-11 珀金埃尔默健康科学股份有限公司 确定产前并发症风险的方法

Also Published As

Publication number Publication date
EP2657697A3 (fr) 2014-02-19
US20140113320A1 (en) 2014-04-24
US8647832B2 (en) 2014-02-11
EP2245180A4 (fr) 2011-06-08
EP2657697B1 (fr) 2016-06-08
EP2245180B1 (fr) 2014-06-18
CA2967508A1 (fr) 2009-07-30
EP2657697A2 (fr) 2013-10-30
CN103969455B (zh) 2016-08-24
CA2713229A1 (fr) 2009-07-30
CN102216468B (zh) 2014-06-11
US8932823B2 (en) 2015-01-13
CA2713229C (fr) 2017-07-11
AU2009206243B2 (en) 2014-10-02
AU2009206243A1 (en) 2009-07-30
PL2245180T3 (pl) 2015-03-31
WO2009094665A1 (fr) 2009-07-30
CA2967508C (fr) 2020-02-25
US20130344503A1 (en) 2013-12-26
EP3109322A1 (fr) 2016-12-28
US20160305950A1 (en) 2016-10-20
EP2245180A1 (fr) 2010-11-03
ES2587077T3 (es) 2016-10-20
US8673582B2 (en) 2014-03-18
US20140113319A1 (en) 2014-04-24
US20100304412A1 (en) 2010-12-02
ES2523220T3 (es) 2014-11-24
CN102216468A (zh) 2011-10-12
CN103969455A (zh) 2014-08-06

Similar Documents

Publication Publication Date Title
HK1162616A1 (en) Methods for determining the risk of prenatal complications
ZA201101970B (en) Multispecific antibodies
EP2359275A4 (fr) Estimation d'une influence
EP2351777A4 (fr) Anticorps anti-muc1
HK1153538A1 (en) Pro-endothelin-1 levels for the prediction of risk of tachyarrhytmic events -1
GB2462829B (en) Measurement method
EP2147309A4 (fr) Procédés de détection de la prééclampsie
GB2471221B (en) Methods
EP2344667A4 (fr) Méthodes de détermination d'haplotype par haplodissection
GB0818650D0 (en) Methods
EP2389104A4 (fr) Identification du niveau de risque foetal pendant le travail
EP2263086A4 (fr) Biomarqueurs
EP2318508A4 (fr) Détermination de l intégrité d arn
PL2183985T3 (pl) Określanie ścieżki pochodzenia
EP2275814A4 (fr) Procédé de mesure d'oligomère a
GB0811360D0 (en) Methods
GB2457797B (en) Covariance based face association
ZA201105184B (en) Biomarker
EP2265641A4 (fr) Biomarqueurs
EP2208986A4 (fr) Procédé de détermination de l'auto-inducteur 2
EP2340037A4 (fr) Procédé de détermination des niveaux de tgf-bêta dans une composition
PL2288920T3 (pl) Sposób określania zakażenia Trichinella
TWI348657B (en) Determination method of edge direction
EP2231868A4 (fr) Méthode de dosage
GB0819405D0 (en) Assay method